HE Healthark Failure Detection in Real-World Evidence Using Anomaly Detection The Hidden Problem Noone Notices in Data
MDA SOC MA Mark Gibson The ‘Service Refugee’ Companies Chasing Patient Voice Research: What They Should Know Currently, the Patient Voice is trending and is chased and embraced as a commercial opportunity by many organisations. Quite a number of…
SCI ECO AM Amanda da Cruz Costa Mudanças climáticas e os tribunais 07 aula da Oxford School of Climate Change , com Rupert Stuart-Smith
ECO PE Petros Magopoulos RWE Aktiengesellschaft Journey and Investment Thesis By Petros Magopoulos | March 2026.
BIO PA Partex.AI Reflections from the webinar “Real-World Data is Transforming Biopharma and Healthcare — How Do We… Date: (16 December 2025)
EI Eiji Sasahara (笹原英司), Ph.D., MBA 米国FDAが医療機器申請時のRWE活用制限を緩和 (2025年12月19日公開) 2025年12月15日、米国食品医薬品局(FDA)は、医薬品および医療機器の承認申請審査におけるリアルワールドエビデンス(RWE)の活用に関する重要な制限を撤廃したことを発表した。
MED ECO VE Veridon Global 2nd Annual EVIDENCE 360: RWE, Pricing & Market Access Summit UK Edition 2026